- Home
- MCRI vs NEO Comparison
MCRI vs NEO Comparison
Compare MCRI & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRI
- NEO
- Stock Information
- Founded
- MCRI 1972
- NEO 2001
- Country
- MCRI United States
- NEO United States
- Employees
- MCRI N/A
- NEO N/A
- Industry
- MCRI Hotels/Resorts
- NEO Precision Instruments
- Sector
- MCRI Consumer Discretionary
- NEO Health Care
- Exchange
- MCRI Nasdaq
- NEO Nasdaq
- Market Cap
- MCRI 1.6B
- NEO 1.9B
- IPO Year
- MCRI 1993
- NEO 1999
- Fundamental
- Price
- MCRI $89.40
- NEO $11.10
- Analyst Decision
- MCRI Hold
- NEO Strong Buy
- Analyst Count
- MCRI 5
- NEO 10
- Target Price
- MCRI $84.00
- NEO $20.00
- AVG Volume (30 Days)
- MCRI 109.9K
- NEO 1.1M
- Earning Date
- MCRI 02-11-2025
- NEO 02-18-2025
- Dividend Yield
- MCRI 1.34%
- NEO N/A
- EPS Growth
- MCRI 18.10
- NEO N/A
- EPS
- MCRI 4.96
- NEO N/A
- Revenue
- MCRI $522,186,000.00
- NEO $660,566,000.00
- Revenue This Year
- MCRI $2.73
- NEO $13.00
- Revenue Next Year
- MCRI $2.07
- NEO $10.74
- P/E Ratio
- MCRI $18.02
- NEO N/A
- Revenue Growth
- MCRI 4.13
- NEO 11.65
- 52 Week Low
- MCRI $64.50
- NEO $10.69
- 52 Week High
- MCRI $96.11
- NEO $19.11
- Technical
- Relative Strength Index (RSI)
- MCRI 56.09
- NEO 29.20
- Support Level
- MCRI $90.43
- NEO $10.69
- Resistance Level
- MCRI $96.11
- NEO $14.73
- Average True Range (ATR)
- MCRI 2.59
- NEO 0.81
- MACD
- MCRI 0.22
- NEO -0.19
- Stochastic Oscillator
- MCRI 52.28
- NEO 10.15
About MCRI Monarch Casino & Resort Inc.
Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.
About NEO NeoGenomics Inc.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.